SCOPUS 정보 검색 플랫폼

Volumn 347, Issue 2-3, 1998, Pages

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

(9) Witkin, Jeffrey a Gasior, Maciej a Acri, Jane a Beekman, Marjolein a Thurkauf, Andrew b Yuan, Jun b DeBoer, Peter c Wikström, Håkan c Dijkstra, Durk c

a NIDA Addiction Research Center (United States)

b NEUROGEN CORPORATION (United States)

c UNIVERSITY OF GRONINGEN (Netherlands)

Author keywords

(+) PD 128,907; Antipsychotic; Dopamine D3 receptor

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; CLOZAPINE; DOPAMINE 3 RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; STEREOTYPY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZOPYRANS; DOPAMINE AGONISTS; MICE; OXAZINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STEREOTYPED BEHAVIOR;

EID: 0032562485 PISSN: 00142999 EISSN: None Source Type: Journal
DOI: 10.1016/S0014-2999(98)00174-5 Document Type: Article

Times cited : (25)

References (8)

1
- 0029584614
- Dopamine agonists in schizophrenia: A review
- Benkert, O., Müller-Siecheneder, F., Wetzel, H., 1995. Dopamine agonists in schizophrenia: a review. Eur. Neuropsychopharmacol., Suppl., pp. 43-53.
- (1995) Eur. Neuropsychopharmacol. , Issue.SUPPL. , pp. 43-53
- Benkert, O.¹ Müller-Siecheneder, F.² Wetzel, H.³

2
- 0030001815
- New antipsychotics: Preclinical and clinical research
- Gerlach J., Casey D.E. New antipsychotics: preclinical and clinical research. Psychopharmacology. 124:1996;1-34.
- (1996) Psychopharmacology , vol.124 , pp. 1-34
- Gerlach, J.¹ Casey, D.E.²

3
- 0029562081
- 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways
- 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275:1995;899-913.
- (1995) J. Pharmacol. Exp. Ther. , vol.275 , pp. 899-913
- Gobert, A.¹ Rivet, J.-M.² Audinot, V.³ Cistarelli, L.⁴ Spedding, M.⁵ Vian, J.⁶ Peglion, J.-L.⁷ Millan, M.⁸

4
- 0029415145
- 3 receptor and schizophrenia: Pharmacological, anatomical and genetic approaches
- 3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches. Eur. Neuropsychopharmacol., Suppl., pp. 3-9.
- (1995) Eur. Neuropsychopharmacol. , Issue.SUPPL. , pp. 3-9
- Griffon, N.¹ Sokoloff, P.² Diaz, J.L.³ Lévesque, D.⁴ Sautel, F.⁵ Schwartz, J.-C.⁶ Simon, P.⁷ Costentin, J.⁸ Garrido, F.⁹ Mann, A.¹⁰ Wermuth, C.¹¹

5
- 0026779303
- Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
- Hoffman D.C. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J. Neural Trans. (GenSect). 89:1992;1-10.
- (1992) J. Neural Trans. (GenSect) , vol.89 , pp. 1-10
- Hoffman, D.C.¹

6
- 0028850552
- Glutamate receptor dysfunction and schizophrenia
- Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
- (1995) Arch. Gen. Psychiatry , vol.52 , pp. 998-1007
- Olney, J.W.¹ Farber, N.B.²

7
- 0029552856
- 3 agonist PD 128907
- 3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275:1995;1355-1366.
- (1995) J. Pharmacol. Exp. Ther. , vol.275 , pp. 1355-1366
- Pugsley, T.A.¹ Davis, M.D.² Akunne, H.C.³ Mackenzie, R.G.⁴ Shih, Y.H.⁵ Damsma, G.⁶ Wikström, H.⁷ Whetzel, S.Z.⁸ Georgic, L.M.⁹ Cooke, L.W.¹⁰ Demattos, S.B.¹¹ Corbin, A.E.¹² Glase, S.A.¹³ Wize, L.D.¹⁴ Dijkstra, D.¹⁵ Heffner, T.G.¹⁶

8
- 0029161068
- Novel dopamine receptors half a decade later
- Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
- (1995) Trends Pharmacol. Sci. , vol.16 , pp. 270-275
- Sokoloff, P.¹ Schwartz, J.-C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.